No biallelic MCM8/MCM9 variant carriers meeting the pathogenicity-based filtering criteria were identified in the SPS case group, fCRCX, and HMF (metastasized CRC and endometrial cancer case groups) cancer-specific cohorts. This evidence concerns the gene MCM8 and endometrial cancer.